About

I am an award-winning writer, editor, photographer and designer with more than 30 years of experience in the media. After studying at the University of Leeds, then London and Anglia HEC, I moved to Canada in the 1980s and started out on the radio while also writing for various music and sports publications, and doing freelance photography. I then edited some magazines before working at a science organization, doing communications and editing publications in a programming language called LaTeX that was challenging but exciting.

Following that, I edited a newspaper, spent some time in the US, and then moved back to the UK where I edited a food B2B publication.
I’ve written, and taken photographs for, hundreds of publications around the world, as well as for books, album covers, DVDs, and shot coverage for documentaries. I’ve edited books, written nine of my own, and done redesigns for several publications. And now I’m writing about biotech, as well as creating videos and a weekly podcast.

I’ve done other things, like running an aquarium, teaching photography and drumming (not at the same time), and running football (soccer) refereeing courses.

In what spare time I have, I love spending time with my wife, son and dog, challenging hikes up the Scottish hills (and down again), playing and writing music, watching baseball and soccer, and collecting memorabilia and autographs.

Articles by Jim Cornall

Forbion raises €1.35B to invest in life science companies

Nanocages developed to deliver small interfering RNAs

Complement Therapeutics raises €72M for eye condition gene therapy

Swedish bacterial resistance study could pave road to new antibiotics

Aer Therapeutics raises $36M to tackle lung diseases

TORL BioTherapeutics launches with $158M to target cancer

ADVERTISEMENT

Researchers explain how some lung tumors avoid immunotherapy

biomodal launches new multiomics sequencing technology

Podcast 14 Apr 2023

Beyond Biotech podcast 41: Sarcoidosis

Parkinson’s cure ‘inevitable’ after biomarker breakthrough

Aspect and Novo Nordisk working on bioprinted tissue for diabetes and obesity

Adaptyv Bio launches to ‘change protein engineering’

ADVERTISEMENT